GM-CSF has been widely used to enhance anti-tumor immune responses of OVs, such as T-VEC, JX594 (VV), and ONCOS-102 (adenovirus) and proved safe in clinical trials [26,27,28,29]. This evidence concerns the gene CSF2 and neoplasm.